Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Triweekly carboplatin as a potential de-intensification agent in concurrent chemoradiation for early-stage HPV-associated oropharyngeal cancer.

Iganej S, Beard BW, Chen J, Buchschacher GL Jr, Abdalla IA, Thompson LDR, Bhattasali O.

Oral Oncol. 2019 Oct;97:18-22. doi: 10.1016/j.oraloncology.2019.07.016. Epub 2019 Aug 2.

PMID:
31421466
2.

Induction chemotherapy followed by concurrent chemoradiation versus concurrent chemoradiation alone in the definitive management of p16-positive oropharyngeal squamous cell carcinoma with low-neck or N3 disease.

Bhattasali O, Han J, Thompson LDR, Buchschacher GL Jr, Abdalla IA, Iganej S.

Oral Oncol. 2018 Mar;78:151-155. doi: 10.1016/j.oraloncology.2018.01.031. Epub 2018 Feb 20.

PMID:
29496043
3.

Concurrent Radiotherapy and Triweekly Carboplatin for the Definitive Treatment of Locally Advanced Laryngeal Carcinoma.

Lu SM, Iganej S, Abdalla IA, Buchschacher GL.

Am J Clin Oncol. 2018 Jun;41(6):595-600. doi: 10.1097/COC.0000000000000330.

PMID:
27635621
4.

Introduction to retroviruses and retroviral vectors.

Buchschacher GL Jr.

Somat Cell Mol Genet. 2001 Nov;26(1-6):1-11. Review.

PMID:
12465459
5.

Approaches to gene therapy for human immunodeficiency virus infection.

Buchschacher GL Jr, Wong-Staal F.

Hum Gene Ther. 2001 Jun 10;12(9):1013-9. Review.

PMID:
11399224
6.

Development of lentiviral vectors for gene therapy for human diseases.

Buchschacher GL Jr, Wong-Staal F.

Blood. 2000 Apr 15;95(8):2499-504. Review.

PMID:
10753827
7.

Gene therapy and the two faces of HIV.

Wong-Staal F, Buchschacher GL Jr.

Gene Ther. 2000 Aug;7(16):1351-2. No abstract available.

8.

Association of murine leukemia virus pol with virions, independent of Gag-Pol expression.

Buchschacher GL Jr, Yu L, Murai F, Friedmann T, Miyanohara A.

J Virol. 1999 Nov;73(11):9632-7.

9.
10.

Molecular targets of gene transfer therapy for HIV infection.

Buchschacher GL Jr.

JAMA. 1993 Jun 9;269(22):2880-6. Review. No abstract available.

PMID:
8497092
11.

Cloning and characterization of the altA alpha-tubulin gene of Physarum.

Cunningham DB, Buchschacher GL Jr, Burland TG, Dove WF, Kessler D, Paul EC.

J Gen Microbiol. 1993 Jan;139(1):137-51.

PMID:
8450305
12.

Analysis of HIV-1 envelope mutants and pseudotyping of replication-defective HIV-1 vectors by genetic complementation.

Delwart EL, Buchschacher GL Jr, Freed EO, Panganiban AT.

AIDS Res Hum Retroviruses. 1992 Sep;8(9):1669-77.

PMID:
1457211
13.

Cells induced to express a human immunodeficiency virus type 1 envelope gene mutant inhibit the spread of wild-type virus.

Buchschacher GL Jr, Freed EO, Panganiban AT.

Hum Gene Ther. 1992 Aug;3(4):391-7.

PMID:
1356022
14.

Human immunodeficiency virus vectors for inducible expression of foreign genes.

Buchschacher GL Jr, Panganiban AT.

J Virol. 1992 May;66(5):2731-9.

15.

A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity.

Freed EO, Delwart EL, Buchschacher GL Jr, Panganiban AT.

Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):70-4.

16.

Preferential expression of one beta-tubulin gene during flagellate development in Physarum.

Paul EC, Buchschacher GL Jr, Cunningham DB, Dove WF, Burland TG.

J Gen Microbiol. 1992 Jan;138(1):229-38.

PMID:
1556551

Supplemental Content

Loading ...
Support Center